Rocket Pharma updates progress on RP-A501 for Danon disease
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
Other reports of this story
- Rocket Pharma upgraded at Goldman Sachs on Danon disease therapy seekingalpha.com